Abstract
Giant coronary artery aneurysms that occur in 0.5 to 1% of patients with Kawasaki disease can be fatal if associated with thrombosis. Some patients may show persistent inflammation and fever despite treatment with repeated doses of intravenous immunoglobulin (IVIG), steroids, and aspirin. This report describes an infant boy with resistant Kawasaki disease who presented with extensive coronary artery involvement and coronary thrombosis. His inflammation was not controlled with multiple doses of IVIG, parenteral and oral steroids, or high-dose aspirin, and he finally needed infliximab, a monoclonal antibody against tumor necrosis factor alpha. The progression of coronary thrombosis was arrested by the platelet glycoprotein 2b/3a receptor blocker, abciximab, during the acute phase of the disease.
This is a preview of subscription content, log in via an institution to check access.
References
Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD et al (2005) Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 146:662–667
Burns JC, Best BM, Mejias A, Mahony L, Fixler DE, Jafri HS et al (2008) Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr 153:833–838
Horigome H, Sekijima T, Miyamoto T (1997) Successful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki disease. Heart 78:517–518
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y (1996) Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385
Koren G, Lavi S, Rose V, Rowe R (1986) Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108:388–392
Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S (2000) Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr 137:177–180
Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387–394
Williams RV, Wilke VM, Tani LY, Minich LL (2002) Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics 109:E4
Yeo Y, Kim T, Ha K, Jang G, Lee J, Lee K et al (2009) Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr 168:157–162
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sivakumar, K., Pavithran, S. Extensive Coronary Aneurysms With Thrombosis in Resistant Kawasaki Disease. Pediatr Cardiol 34, 444–446 (2013). https://doi.org/10.1007/s00246-012-0285-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-012-0285-9